KA
CEMI

Kovack Advisors’s Chembio diagnostics, Inc. CEMI Stock Holding History

Kovack Advisors’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-16,249
Closed -$98K – 426
2017
Q2 		$98K Sell
16,249
-2,000
-11% -$12.5K 0.03% 356
2017
Q1 		$97K Sell
18,249
-15,260
-46% -$88.9K 0.04% 281
2016
Q4 		$228K Buy
+33,509
New +$232K 0.11% 210

Other funds holding CEMI

ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCA
Benchmark Capital Advisors New York $101M AUM 0.8% 1-Year Est. Return

Kovack Advisors's CEMI Position: Q3 2017 in Review

Kovack Advisors sold out of Chembio diagnostics, Inc. (CEMI) in Q3 2017, closing a stake of 16,249 shares — an estimated $98K sold.

Kovack Advisors first reported a position in CEMI in Q4 2016 and held it in 3 quarters. The position peaked at $228K in Q4 2016. 21 funds tracked by Wall St. Rank hold CEMI as of Q3 2017.

  • Kovack Advisors reported no remaining Chembio diagnostics, Inc. position as of Q3 2017 after selling out during the quarter.
  • Kovack Advisors sold 16,249 Chembio diagnostics, Inc. shares in Q3 2017, an estimated $98K.
  • Kovack Advisors first reported a position in Chembio diagnostics, Inc. in Q4 2016 and held it in 3 quarters.
  • Kovack Advisors's Chembio diagnostics, Inc. position peaked at $228K in Q4 2016.
  • 21 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q3 2017.

Based on Kovack Advisors's 13F filing for Q3 2017, filed 2 Aug 2018.